BiologyWorks™ was formed in 2019 to create simple, rapid diagnostic tests for infections, diseases, and contaminations. Our mission is to give individuals the opportunity to be the first to receive their test results…not the last.
The company is ISO 13485-certified and is led by a veteran group of biologists, engineers, and creatives. Our chemistry is patent-protected and based on years of research originating with the Alfred Mann Foundation, as well as underwritten by a grant from the Bill & Melinda Gates Foundation. While SARS-CoV-2 is our lead target, we are expanding our work to address additional critical infection and disease gene sequences.
We believe in access to reliable diagnostic testing for all. Providing certainty for individuals and their communities is what motivates us every day.
